183 related articles for article (PubMed ID: 22642961)
1. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.
Zai GC; Zai CC; Chowdhury NI; Tiwari AK; Souza RP; Lieberman JA; Meltzer HY; Potkin SG; Müller DJ; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):96-101. PubMed ID: 22642961
[TBL] [Abstract][Full Text] [Related]
2. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.
Tsai A; Liou YJ; Hong CJ; Wu CL; Tsai SJ; Bai YM
Neuromolecular Med; 2011 Dec; 13(4):328-33. PubMed ID: 21956459
[TBL] [Abstract][Full Text] [Related]
3. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia.
Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR
Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059
[TBL] [Abstract][Full Text] [Related]
4. The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.
Fonseka TM; Tiwari AK; Gonçalves VF; Lieberman JA; Meltzer HY; Goldstein BI; Kennedy JL; Kennedy SH; Müller DJ
World J Biol Psychiatry; 2015 Jan; 16(1):45-56. PubMed ID: 25560300
[TBL] [Abstract][Full Text] [Related]
5. Association of the BDNF Val66Met polymorphism with BMI in chronic schizophrenic patients and healthy controls.
Fang H; Zhen YF; Liu XY; Xu G; Soares JC; Zhao J; Zhang XY
Int Clin Psychopharmacol; 2016 Nov; 31(6):353-7. PubMed ID: 27483421
[TBL] [Abstract][Full Text] [Related]
6. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
[TBL] [Abstract][Full Text] [Related]
7. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
[TBL] [Abstract][Full Text] [Related]
8. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
9. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
Tiwari AK; Zai CC; Meltzer HY; Lieberman JA; Müller DJ; Kennedy JL
Hum Psychopharmacol; 2010 Apr; 25(3):253-9. PubMed ID: 20373477
[TBL] [Abstract][Full Text] [Related]
10. TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.
Li S; Xu C; Tian Y; Wang X; Jiang R; Zhang M; Wang L; Yang G; Gao Y; Song C; He Y; Zhang Y; Li J; Li WD
Sci Rep; 2017 Mar; 7():45203. PubMed ID: 28327672
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia.
Zhang JP; Lencz T; Geisler S; DeRosse P; Bromet EJ; Malhotra AK
Schizophr Res; 2013 May; 146(1-3):285-8. PubMed ID: 23433505
[TBL] [Abstract][Full Text] [Related]
12. BDNF polymorphisms are associated with schizophrenia onset and positive symptoms.
Zhang XY; Chen DC; Tan YL; Tan SP; Luo X; Zuo L; Soares JC
Schizophr Res; 2016 Jan; 170(1):41-7. PubMed ID: 26603468
[TBL] [Abstract][Full Text] [Related]
13. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
Bonaccorso S; Sodhi M; Li J; Bobo WV; Chen Y; Tumuklu M; Theleritis C; Jayathilake K; Meltzer HY
Bipolar Disord; 2015 Aug; 17(5):528-35. PubMed ID: 25874530
[TBL] [Abstract][Full Text] [Related]
14. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
[TBL] [Abstract][Full Text] [Related]
15. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
16. BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia.
Han M; Deng C
Neurosci Lett; 2020 May; 726():133870. PubMed ID: 30312750
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study.
Xu M; Li S; Xing Q; Gao R; Feng G; Lin Z; St Clair D; He L
Eur J Hum Genet; 2010 Jun; 18(6):707-12. PubMed ID: 20087404
[TBL] [Abstract][Full Text] [Related]
20. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
Malhotra AK; Correll CU; Chowdhury NI; Müller DJ; Gregersen PK; Lee AT; Tiwari AK; Kane JM; Fleischhacker WW; Kahn RS; Ophoff RA; Meltzer HY; Lencz T; Kennedy JL
Arch Gen Psychiatry; 2012 Sep; 69(9):904-12. PubMed ID: 22566560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
